Abstract
Insulin Resistance (IR) is a physiological condition in which pancreatic cells fail to respond to normal actions of insulin hormone. It is a milestone for the development of diabetes and its complications. The current approach for the treatment of the diabetes and insulin resistance includes pharmacotherapeutics. However, this therapy includes the development of drug tolerance, potential toxicity and inadequate relief warranting the investigation of newer approaches for treatment. A potentially safe and effective therapeutic treatment for insulin resistance (IR) in diabetes is required. The current research is focused on herbal or phytochemical drugs. The potential herbal targets with insulin mimetic, secretagogues and promising activity are under the scope of this review. In this review, we have discussed the herbal targets and non-pharmacological approaches for the treatment of IR in diabetes. This review aims to compile the relevant information regarding various phases of drug development for the management of the insulin resistance and highlight the future prospective for its treatment by natural and semi-synthetic drugs.
Keywords: Diabetes, insulin resistance, semi-synthetic drugs, treatment, pharmacotherapeutics, natural drugs.
Graphical Abstract
Current Psychopharmacology
Title:Insulin Resistance in Diabetes: Present and Future Prospective of Treatment
Volume: 7
Author(s): Anil Kumar*, Ruchika Mittal and Ashmeen Kaur
Affiliation:
- Pharmacology Division, University Institute of Pharmaceutical Sciences, UGC Centre of Advanced Study, Panjab University, Chandigarh,India
Keywords: Diabetes, insulin resistance, semi-synthetic drugs, treatment, pharmacotherapeutics, natural drugs.
Abstract: Insulin Resistance (IR) is a physiological condition in which pancreatic cells fail to respond to normal actions of insulin hormone. It is a milestone for the development of diabetes and its complications. The current approach for the treatment of the diabetes and insulin resistance includes pharmacotherapeutics. However, this therapy includes the development of drug tolerance, potential toxicity and inadequate relief warranting the investigation of newer approaches for treatment. A potentially safe and effective therapeutic treatment for insulin resistance (IR) in diabetes is required. The current research is focused on herbal or phytochemical drugs. The potential herbal targets with insulin mimetic, secretagogues and promising activity are under the scope of this review. In this review, we have discussed the herbal targets and non-pharmacological approaches for the treatment of IR in diabetes. This review aims to compile the relevant information regarding various phases of drug development for the management of the insulin resistance and highlight the future prospective for its treatment by natural and semi-synthetic drugs.
Export Options
About this article
Cite this article as:
Kumar Anil *, Mittal Ruchika and Kaur Ashmeen , Insulin Resistance in Diabetes: Present and Future Prospective of Treatment, Current Psychopharmacology 2018; 7 (2) . https://dx.doi.org/10.2174/2211556007666180309155102
DOI https://dx.doi.org/10.2174/2211556007666180309155102 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Use of Positron Emission Tomography for Target Volume Definition
Current Radiopharmaceuticals Computational & Statistical Methodologies to Identify Biomarkers in Cancer
Current Cancer Therapy Reviews Metabolism in Patients with Rheumatoid Arthritis: Resting Energy Expenditure, Physical Activity and Diet-Induced Thermogenesis. Invited Review
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Synthesis, Antidiabetic and Hypolipidemic Activities of New Diethylamine and Triethoxysilyl Derivatives of Tolbutamide on Rats
Medicinal Chemistry Dimeric NGF Mimetic Attenuates Hyperglycaemia and DNA Damage in Mice with Streptozotocin-Induced Early-Stage Diabetes
Endocrine, Metabolic & Immune Disorders - Drug Targets Recent Developments in Targeted Therapies of the RAF-MEK and PI3KAKT Pathways in Cancer Treatment
Current Cancer Therapy Reviews Comparative Effect of Telmisartan vs Lisinopril on Blood Pressure in Patients of Metabolic Syndrome
Endocrine, Metabolic & Immune Disorders - Drug Targets Therapeutic Potential of Erythropoietin in Retinal and Optic Nerve Diseases
CNS & Neurological Disorders - Drug Targets Do You See What I See: Recognition of Protozoan Parasites by Toll-Like Receptors
Current Immunology Reviews (Discontinued) Cerebrovascular Complications of Diabetes: SGLT-2 Inhibitors as a Promising Future Therapeutics
Current Drug Targets The Personalized Approach for Detecting Prediabetes and Diabetes
Current Diabetes Reviews Effect of Flavonoids on Human Health: Old Subjects but New Challenges
Recent Patents on Biotechnology Brefeldin A Inhibits Cancer Stem Cell Properties in Human Lung Cancer Cells
Current Signal Transduction Therapy Drug Delivery Systems for Imaging and Therapy of Parkinson's Disease
Current Neuropharmacology Current Experimental, Bioinformatic and Statistical Methods used in NMR Based Metabolomics
Current Metabolomics Proteomics Analysis Revealed an Altered Left Ventricle Protein Profile in a Mouse Model of Transverse Aortic Constriction
Protein & Peptide Letters Polymeric Nanomaterials as Nanomembrane Entities for Biomolecule and Drug Delivery
Current Pharmaceutical Design Recognition and Impact of Host-derived Molecules on Bacterial Cell-tocell Signalling Pathways
Medicinal Chemistry Drug and Medical Device Interactions: Stent Thrombosis and Personalizing Clopidogrel Therapy
Current Pharmacogenomics and Personalized Medicine Meet Our Editorial Board Member
Current Bioinformatics